[1] 徐文严.加强结缔组织病的临床研究工作.中华皮肤科杂志,1999,32:1.
[2] 陈志强,徐文严.如何深入研究结缔组织病.中华皮肤科杂志,2002,35:8.
[3] Oelke K, Richardson B. Pathogenesis of lupus. Arthritis Rheum,2002,47:343-345.
[4] Takada K, Illei GG, Boumpas DT. Cyclophosphamide for the treatment of systemic lupus erythematosus. Lupus, 2001,10:154-161.
[5] Callen JP. Dermatomyositis: diagnosis, evaluation and management.Minerva Med, 2002,93:157-167.
[6] Hawk A. Localized and systemic scleroderma. Semin Cutan Med Surg, 2001,20:27-37.
[7] 叶冬青,施小明,陆伟,等.系统性红斑狼疮遗传流行病学研究.中华皮肤科杂志,2003,36:7-9
[8] 陆春,李娟,熊文杰,等.异基因造血干细胞移植治疗BXSB狼疮鼠.中华皮肤科杂志,2003,36:25-27.
[9] 付继成,徐世正,周心房,等.胚胎胸腺移植治疗BXSB小鼠自发性系统性红斑狼疮的研究.中华皮肤科杂志,2003,36:28-30.
[10] 梁伶,郑文军.广西壮族系统性红斑狼疮与HLA-DRB1等位基因相关性研究.中华皮肤科杂志,2003,36:23-24 |
